These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Severe anemia caused by dominant mutations in Krüppel-like factor 1 (KLF1). Kulczynska-Figurny K; Bieker JJ; Siatecka M Mutat Res Rev Mutat Res; 2020; 786():108336. PubMed ID: 33339573 [TBL] [Abstract][Full Text] [Related]
6. A Case of Congenital Dyserythropoeitic Anemia Type IV Caused by E325K Mutation in Erythroid Transcription Factor KLF1. Ortolano R; Forouhar M; Warwick A; Harper D J Pediatr Hematol Oncol; 2018 Aug; 40(6):e389-e391. PubMed ID: 29200155 [TBL] [Abstract][Full Text] [Related]
7. Erythroid transcription factor EKLF/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: review of all reported cases and development of a clinical diagnostic paradigm. Jaffray JA; Mitchell WB; Gnanapragasam MN; Seshan SV; Guo X; Westhoff CM; Bieker JJ; Manwani D Blood Cells Mol Dis; 2013 Aug; 51(2):71-5. PubMed ID: 23522491 [TBL] [Abstract][Full Text] [Related]
8. KLF1 E325K-associated Congenital Dyserythropoietic Anemia Type IV: Insights Into the Variable Clinical Severity. Ravindranath Y; Johnson RM; Goyette G; Buck S; Gadgeel M; Gallagher PG J Pediatr Hematol Oncol; 2018 Aug; 40(6):e405-e409. PubMed ID: 29300242 [TBL] [Abstract][Full Text] [Related]
9. A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia. Arnaud L; Saison C; Helias V; Lucien N; Steschenko D; Giarratana MC; Prehu C; Foliguet B; Montout L; de Brevern AG; Francina A; Ripoche P; Fenneteau O; Da Costa L; Peyrard T; Coghlan G; Illum N; Birgens H; Tamary H; Iolascon A; Delaunay J; Tchernia G; Cartron JP Am J Hum Genet; 2010 Nov; 87(5):721-7. PubMed ID: 21055716 [TBL] [Abstract][Full Text] [Related]
10. Comment on: Congenital dyserythropoietic anemia type IV with KLF1 E325K mutation: A new case with dysmorphic male genitalia. Report of a second case. Dorosh O; Bodak K; Tsymbalyuk-Voloshyn I; Makukh H; Kreminska O; Hrytsiuk I; Battisti L; Erlacher M; Wlodarski M; McGlacken-Byrne SM; Achermann JC; Niemeyer CM; Yoshimi A Pediatr Blood Cancer; 2024 Nov; 71(11):e31294. PubMed ID: 39192712 [No Abstract] [Full Text] [Related]
11. A Very Rare Congenital Dyserythropoietic Anemia Variant-Type IV in a Patient With a Novel Mutation in the KLF1 Gene: A Case Report and Review of the Literature. Belgemen-Ozer T; Gorukmez O J Pediatr Hematol Oncol; 2020 Aug; 42(6):e536-e540. PubMed ID: 32032242 [TBL] [Abstract][Full Text] [Related]
12. Congenital dyserythropoietic anemia type IV with high fetal hemoglobin caused by heterozygous KLF1 p.Glu325Lys: first report in an Indian infant. Jamwal M; Aggarwal A; Sharma P; Bansal D; Das R Ann Hematol; 2021 Jan; 100(1):281-283. PubMed ID: 32221653 [No Abstract] [Full Text] [Related]
13. Erythroid Krüppel-Like Factor (KLF1): A Surprisingly Versatile Regulator of Erythroid Differentiation. Bieker JJ; Philipsen S Adv Exp Med Biol; 2024; 1459():217-242. PubMed ID: 39017846 [TBL] [Abstract][Full Text] [Related]
14. Hemoglobin switching in mice carrying the Korporaal A; Gillemans N; Heshusius S; Cantú I; van den Akker E; van Dijk TB; von Lindern M; Philipsen S Haematologica; 2021 Feb; 106(2):464-473. PubMed ID: 32467144 [TBL] [Abstract][Full Text] [Related]
15. An Unusual Hydrops Fetalis Associated with Compound Heterozygosity for Krüppel-like Factor 1 mutations. Lee HH; Mak AS; Kou KO; Poon CF; Wong WS; Chiu KH; Au PK; Chan KY; Kan AS; Tang MH; Leung KY Hemoglobin; 2016 Nov; 40(6):431-434. PubMed ID: 28361594 [TBL] [Abstract][Full Text] [Related]
16. Modelling the erythroblastic island niche of dyserythropoietic anaemia type IV patients using induced pluripotent stem cells. May A; Ventura T; Fidanza A; Volmer H; Taylor H; Romanò N; D'Souza SL; Bieker JJ; Forrester LM Front Cell Dev Biol; 2023; 11():1148013. PubMed ID: 37113767 [No Abstract] [Full Text] [Related]